Skip to main content
Retour
Watch Compare

Lipocine Inc.

Qualité des données : 100%
LPCN
NASDAQ Manufacturing Chemicals
2,20 €
▲ 0,11 € (5,26%)
Cap. Boursière: 16,06 M
Prix
2,20 €
Cap. Boursière
16,06 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Revenue declined -40,84% annually over 5 years
Earnings declined -115371,85% over the past year
Negative free cash flow of -9,85 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 41,51%
Capital efficient — spends only 4,56% of revenue on capex

Croissance

Revenue Growth (5Y)
-40,84%
En dessous de la moyenne du secteur (1,82%)
Revenue (1Y)-82,35%
Earnings (1Y)-115371,85%
FCF Growth (3Y)N/A

Qualité

Return on Equity
-61,58%
En dessous de la moyenne du secteur (-53,58%)
ROIC-52,40%
Net Margin-487,06%
Op. Margin-524,69%

Sécurité

Debt / Equity
N/A
Current Ratio8,25
Interest CoverageN/A

Valorisation

PE (TTM)
-1,67
En dessous de la moyenne du secteur (-1,48)
P/B Ratio1,14
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1366 pairs)
Métrique Action Médiane du Secteur
P/E -1,7 -1,5
P/B 1,1 1,6
ROE % -61,6 -53,6
Net Margin % -487,1 -41,5
Rev Growth 5Y % -40,8 1,8
D/E — 0,3

Objectif de Cours des Analystes

1 analyste
Buy
Actuel
2,20 €
+400.0%
Objectif
11,00 €
11,00 €
11,00 €
11,00 €
Prévisions
BPA Prévisionnel -1,35 €
CA Est. 1,09 M

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 -1,35 €
-1,35 € – -1,35 €
 1,09 M 1
FY2026 -2,01 €
-2,10 € – -1,91 €
 650 000,0 2

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 -0,61 € -0,42 € +31,2%
Q32025 -0,54 € -0,59 € -9,3%
Q22025 -0,40 € -0,41 € -2,5%
Q12025 -0,35 € -0,35 € 0,0%

All Fundamental Metrics
Growth
Revenue Growth (1Y) -82,35% Revenue Growth (3Y) N/A
Earnings Growth (1Y) -115371,85% Earnings Growth (3Y) N/A
Revenue Growth (5Y) -40,84% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1,98 M Net Income (TTM) -9,63 M
ROE -61,58% ROA -55,57%
Gross Margin N/A Operating Margin -524,69%
Net Margin -487,06% Free Cash Flow (TTM) -9,85 M
ROIC -52,40% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 8,25
Interest Coverage N/A Asset Turnover 0,11
Working Capital 14,00 M Tangible Book Value 14,14 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,67 Forward P/E N/A
P/B Ratio 1,14 P/S Ratio 8,12
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 14,73 Fwd Earnings Yield N/A
FCF Yield -61,34%
Market Cap 16,06 M Enterprise Value 12,16 M
Per Share
EPS (Diluted TTM) -1,69 Revenue / Share 0,27
FCF / Share -1,35 OCF / Share -1,34
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 4,56% FCF Conversion 102,32%
SBC-Adj. FCF -10,15 M Growth Momentum -41,51

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1,98 M 11,20 M -2,85 M 500 000,0 16,14 M
Net Income -9,63 M 8 352,0 -16,35 M -10,76 M -634 399,0
EPS (Diluted) -1,69 -3,14 -3,14 -0,13 -0,01
Gross Profit — — — — —
Operating Income -10,37 M -1,16 M -17,93 M -12,12 M 3,15 M
EBITDA — — — — —
R&D Expenses 8,58 M 7,35 M 10,18 M 8,56 M 7,67 M
SG&A Expenses — — — — —
D&A 60 782,0 41 106,0 28 661,0 9 453,0 380,0
Interest Expense — — 27 098,0 27 098,0 203 292,0
Income Tax 200,0 681,0 755,0 681,0 200,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 17,01 M 22,51 M 23,00 M 37,54 M 52,48 M
Total Liabilities 2,53 M 1,51 M 2,63 M 1,91 M 6,91 M
Shareholders' Equity 14,48 M 21,00 M 20,37 M 35,63 M 45,57 M
Total Debt — — — — 1,67 M
Cash & Equivalents 5,21 M 6,21 M 4,77 M 3,15 M 2,95 M
Current Assets 16,88 M 22,32 M 22,86 M 34,14 M 46,38 M
Current Liabilities 2,53 M 1,51 M 2,63 M 1,68 M 5,62 M